Plasma Microbial Cell-Free DNA Metagenomic Sequencing Bridges Gaps in the Diagnosis, Epidemiology and Surveillance of Legionella Infections

Read full text Summarise with VIRAT
Authors: Frederick S. Nolte, Martin S. Lindner, Shivkumar Venkatasubrahmanyam, Chiagozie Ifeoma Pickens, Lindsay S Lim, Vincent P. Hsu, Sarah Y. Park, Bradley A. Perkins, Richard G. Wunderink
Cited by: 0
References: 23

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

ABSTRACT Conventional diagnostic methods (CDM) for Legionella preferentially detect L. pneumophila and frequently fail to identify non-pneumophila species (NPLS), obscuring the full clinical spectrum of infection and limiting surveillance accuracy. We analyzed plasma microbial cell-free DNA (mcfDNA) sequencing detections of Legionella spp. from a large clinical cohort tested between 2018 and 2024 and compared species distributions with culture and PCR confirmed cases reported in the most recent national surveillance datasets (2018-2021). To contextualize the clinical impact, we reviewed published reports in which mcfDNA sequencing was used to diagnose legionellosis (2021–2025) and evaluated real-world performance data from a hospital contributing 8.9% of detections within the cohort (Hospital A). mcfDNA sequencing identified proportionally fewer L. pneumophila , more NPLS, and fewer unresolved species than the CDC reports (all p

Fields of Study & Subjects

Legionella and Acanthamoeba research Bacterial Identification and Susceptibility Testing Infections and bacterial resistance

Publication details

Journal / source
medRxiv
Publication date
26 March 2026
Language
EN
Document type
Preprint